Cargando…
Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma
BACKGROUND: Tumor response and survival varies in patients treated with transarterial chemoembolization (TACE) for intermediate stage hepatocellular carcinoma (HCC) and may be associated with several factors. PURPOSE: To evaluate safety and efficacy of TACE in patients with intermediate stage HCC an...
Autores principales: | Nyman, Sofi Sennefelt, Creusen, Angeliki Dimopoulou, Johnsson, Ulf, Rorsman, Fredrik, Vessby, Johan, Barbier, Charlotte Ebeling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490438/ https://www.ncbi.nlm.nih.gov/pubmed/34665054 http://dx.doi.org/10.1177/02841851211041832 |
Ejemplares similares
-
Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
por: Nyman, Sofi Sennefelt, et al.
Publicado: (2022) -
Apparent diffusion coefficients (ADC) in response assessment of
transarterial radioembolization (TARE) for liver metastases of neuroendocrine
tumors (NET): a feasibility study
por: Katharina Ingenerf, Maria, et al.
Publicado: (2021) -
Rectal cancer staging using MRI: adherence in reporting to
evidence-based practice
por: Alvfeldt, Gustav, et al.
Publicado: (2020) -
Detecting lymph node metastasis of esophageal cancer on dual-energy
computed tomography
por: Sun, Xuyang, et al.
Publicado: (2020) -
Can optimized model-based iterative reconstruction improve the contrast of liver lesions in CT?
por: Oppenheimer, Jonas, et al.
Publicado: (2022)